Definition: Steroid hormones produced in the adrenal cortex, critical for various bodily functions.
Function: Involved in metabolism, immune response regulation, and stress response.
Uses:
Treat allergic reactions, inflammation, and autoimmune conditions.
Manage diseases like asthma and rheumatoid arthritis.
Symptoms:
Rash, lacrimation, runny nose, sneezing, red eyes, itching.
Types of Treatment:
Local allergy: Use topical antihistamines (e.g., Benadryl cream).
Systemic exposure: Prefer non-drowsy antihistamines (e.g., Reactin).
Eye symptoms: Topical antihistamines (e.g., Patanol drops).
Prophylaxis: Use leukotriene modifiers like Singulair before high doses of allergens.
Description: Severe allergic reaction leading to systemic inflammatory response.
Symptoms:
Evidence of allergy, bronchoconstriction, hypotension.
Treatment Focus:
Maintain Airway, Breathing, and Circulation (ABCs).
Medications: Epinephrine IM, dexamethasone IV, antihistamines IV, and IV fluids.
Classification: Endogenous neurotransmitter and non-selective adrenergic agonist (acts on alpha and beta receptors).
Administration: Routes include IV and IM with rapid onset (20 mins duration).
Trade Names: Epipen, Adrenalin.
Minimal Side Effects:
Safe for acute treatment (e.g., anaphylaxis) via local route.
Long term Risks:
Higher chances of adverse effects with systemic route.
Negative Feedback: Long-term use can suppress adrenal glucocorticoid synthesis.
Chronic Conditions:
Allergic rhinitis, dermatitis, psoriasis, arthritis, IBD, asthma, COPD.
Treatment includes evaluating clinical efficacy and balancing risks.
Stages: Initial acute inflammation is followed by chronic inflammation, characterized by:
Lymphocyte and macrophage proliferation, tissue growth factors, and destruction.
Leads to scar formation and changes in tissue properties, increasing susceptibility to abnormal growth.
Prevalence: Up to 40% of the population.
Triggers: Inhaled allergens like pollen and dust.
Symptoms: Nasal discharge, conjunctivitis, sneezing.
Lab Findings: High eosinophil count.
Treatment: Antihistamines and intranasal corticosteroids (e.g., Flonase, Nasonex).
Description: Common chronic inflammatory skin disease associated with allergies.
Characteristics: Itchy skin, potential for bacterial/viral super-infections.
Treatment: Moisturizers, topical glucocorticoids, and antihistamines.
Characteristics: Chronic inflammatory skin condition characterized by dry, scaly patches, often on extensor surfaces.
Treatment: Glucocorticoids (local/mild or systemic during flare-ups), DMARDs, and UV light therapy.
Definition: A degenerative disorder affecting articular cartilage.
Risk Factors: Mechanical stress, obesity, age.
Pathophysiology: Causes chronic inflammation leading to cartilage destruction and pain.
Treatment: NSAIDs and glucocorticoids, including intra-articular injection when necessary.
Overview: Chronic autoimmune disease causing joint inflammation and systemic symptoms.
Affected Areas: Joints, heart, lungs, kidneys, eyes.
Signs and Symptoms: Inflammation, pain, limited function, systemic fatigue.
Main Treatments: NSAIDs, glucocorticoids, biologic response modifiers (e.g., Infliximab, Methotrexate).
OA: Degenerative, fewer joints affected, cartilage loss, and joint space narrowing.
RA: Inflammatory, typical swelling of synovial membranes, and potential for bone erosion.